These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2007 related items for PubMed ID: 26093190

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Weight change at 12 months in users of three progestin-only contraceptive methods.
    Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF.
    Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
    [Abstract] [Full Text] [Related]

  • 5. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D, Spector H, Monteith C, Chen PL, Hart C.
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial.
    Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro TD, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.
    PLoS One; 2024 Feb; 19(5):e0299802. PubMed ID: 38722832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR, Klein DA, Olsen CH, Weir LF, Roberts TA.
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S, WHO Study Group on Contraceptive Implants for Women.
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [Abstract] [Full Text] [Related]

  • 13. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Krashin JW, Stuart GS, Garrett J, Spector H, Bryant AG, Charm S, Morse JE.
    Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intimate Partner Violence and Effectiveness Level of Contraceptive Selection Post-Abortion.
    Drew LB, Mittal M, Thoma ME, Harper CC, Steinberg JR.
    J Womens Health (Larchmt); 2020 Aug; 29(8):1142-1149. PubMed ID: 31721639
    [Abstract] [Full Text] [Related]

  • 16. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
    Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C.
    BMC Womens Health; 2024 Mar 08; 24(1):167. PubMed ID: 38459552
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I, LARC Guideline Development Group.
    Hum Reprod; 2008 Jun 08; 23(6):1338-45. PubMed ID: 18372257
    [Abstract] [Full Text] [Related]

  • 19. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
    Beesham I, Bosman S, Beksinska M, Scoville CW, Smit J, Nanda K.
    Contraception; 2022 Apr 08; 108():37-43. PubMed ID: 34848180
    [Abstract] [Full Text] [Related]

  • 20. Introduction of postabortion contraception, prioritizing long-acting reversible contraceptives, in the principal maternity hospital of Gabon.
    Mayi-Tsonga S, Obiang PA, Minkobame U, Ngouafo D, Ambounda N, de Souza MH.
    Int J Gynaecol Obstet; 2014 Jul 08; 126 Suppl 1():S45-8. PubMed ID: 24745694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 101.